Please login to the form below

Not currently logged in
Email:
Password:

classic Hodgkin's lymphoma

This page shows the latest classic Hodgkin's lymphoma news and features for those working in and with pharma, biotech and healthcare.

Opdivo edges closer to first haematological cancer indication

Opdivo edges closer to first haematological cancer indication

Opdivo edges closer to first haematological cancer indication. EMA begins review of BMS' classic Hodgkin’ s lymphoma inhibitor treatment. ... BMS is seeking approval of Opdivo (nivolumab) for the treatment of classic Hodgkin's lymphoma (cHL) in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics